Dow Inc
0A1S.L
â‚Ŧ20.10 0.50%
Exchange: LSE | Sector: Basic Materials | Industry: Chemicals
Q2 2025
Published: Jul 25, 2025

Earnings Highlights

  • Revenue of $10.10B down 7.4% year-over-year
  • EPS of $-1.18 decreased by 290.3% from previous year
  • Gross margin of 5.2%
  • Net income of -801.00M
  • "The current geopolitical landscape has undeniably put pressure on our supply chain efficiency, and we are actively looking at ways to bolster this aspect of our operations." - CEO

Dow Inc Q2 2025 Financial Results Report - Underperformance Amid Market Challenges

Executive Summary

In Q2 2025, Dow Inc (LSE: 0A1S.L) reported significantly disappointing financial results, with revenue declining by 7.43% year-over-year to $10.10 billion, alongside a staggering net loss of $801 million, marking a 282.46% decrease from the previous year's profit. This poor performance can be attributed to adverse market conditions, supply chain disruptions, and rising operational costs within the Basic Materials sector. Despite an encouraging portfolio of materials science solutions, management acknowledged ongoing challenges, particularly in the pricing of raw materials and competitive pressures in Europe and Asia. The situation has prompted management to recalibrate its strategy, emphasizing cost-cutting measures and innovation in product offerings to mitigate the impact of declining profits and bolster future performance. As a result, investors are advised to closely monitor developments surrounding these strategic adjustments, as the company navigates a complex market landscape

Key Performance Indicators

Revenue

10.10B
QoQ: -3.13% | YoY:-7.43%

Gross Profit

521.00M
5.16% margin
QoQ: -22.35% | YoY:-60.65%

Operating Income

-10.00M
QoQ: -107.25% | YoY:-101.51%

Net Income

-801.00M
QoQ: -160.91% | YoY:-282.46%

EPS

-1.18
QoQ: -168.18% | YoY:-290.32%

Revenue Trend

Margin Analysis

Key Insights

  • **Quarterly Revenue**: $10.10 billion, down 3.13% from Q1 2025.
  • **Year-over-Year Revenue Change**: Decreased by 7.43%. **Profitability**
  • **Net Income**: $-801 million, resulting in an EPS of $-1.18.
  • **Gross Profit Margin**: 5.16%, down from 12.13% in Q2 2024.
  • **Operating Income**: $-10 million, representing an operating margin decline. **Balance Sheet Health**

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 10,104.00 -1.18 -7.4% View
Q1 2025 10,431.00 -0.44 -3.1% View
Q4 2024 10,405.00 -0.08 -2.0% View
Q3 2024 10,879.00 0.30 +1.4% View
Q2 2024 10,915.00 0.62 -4.4% View